Websites linking back to opdivoinformation.com
3 websites are linking back to opdivoinformation.com in their content.
Total results: 3
Domains on this page: 3
Results:
OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)http://portalrankings.com/info/opdivoinformationhcp.com
OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.
- Updated On (Date): 2017-Oct-06
- Expiration time: 2018-Oct-10
- Website Registered On (Date): 2016-Oct-10
OPDIVO® (nivolumab) | Patient Gatewayhttp://portalrankings.com/info/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
- Updated On (Date): 2016-Nov-01
- Expiration time: 2017-Nov-06
- Website Registered On (Date): 2012-Nov-06
OPDIVO® (nivolumab) | Patients | Advanced Urothelial Carcinoma (Bladder Cancer)http://portalrankings.com/info/opdivoinformation.com
Information for consumers about OPDIVO® (nivolumab), a prescription medicine for previously treated bladder cancer (urothelial carcinoma) that has spread or grown. See Indication and Important Safety Information.
- Updated On (Date): 2017-Oct-06
- Expiration time: 2018-Oct-10
- Website Registered On (Date): 2016-Oct-10